A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
CRISPR Therapeutics
NuCana plc
Medicenna Therapeutics, Inc.
Cancer Research UK
Novartis
University Hospital, Antwerp
University Hospital, Antwerp
University Hospital, Antwerp
Institut Bergonié